logo

Astrazeneca Plc (AZN.L)



Trade AZN.L now with
  Date
  Headline
9/17/2021 7:35:18 AM AstraZeneca Announces COAST Phase II Trial Results
9/9/2021 11:07:09 AM AstraZeneca's IMFINZI And Tremelimumab With Chemotherapy Improve PFS By 28% In 1st-line Stage IV NSCLC
9/9/2021 2:05:30 AM AstraZeneca Says MANDALA And DENALI Phase III Trials Of PT027 Meet All Primary Endpoints
9/8/2021 6:58:34 AM HUTCHMED, AstraZeneca Initiate SANOVO Phase III Trial Of ORPATHYS And TAGRISSO Combination For Lung Cancer In China
9/3/2021 2:03:50 AM AstraZeneca's Ultomiris Approved In EU For Expanded Use To Include Children In Paroxysmal Nocturnal Haemoglobinuria
8/26/2021 2:12:17 AM AstraZeneca: Forxiga Approved In Japan For Chronic Kidney Disease In Patients With And Without Type-2 Diabetes
8/26/2021 2:05:46 AM AstraZeneca Says ALXN1840 FoCus Phase III Trial In Wilson Disease Meets Primary Endpoint
8/20/2021 2:06:33 AM AstraZeneca Says AZD7442 Prophylaxis Trial Meets Primary Endpoint